au.\*:("ELISAF, M. S")
Results 1 to 25 of 56
Selection :
Ezetimibe-associated adverse effects : what the clinician needs to knowFLORENTIN, M; LIBEROPOULOS, E. N; ELISAF, M. S et al.International journal of clinical practice (Esher). 2008, Vol 62, Num 1, pp 88-96, issn 1368-5031, 9 p.Article
Hyponatraemia in a patient with hepatic cirrhosisMILIONIS, H. J; ELISAF, M. S.Nephrology, dialysis, transplantation (Print). 1999, Vol 14, Num 3, pp 787-789, issn 0931-0509Article
Hyperosmolar nonketotic syndrome with hypernatremia : How can we monitor treatment?LIAMIS, G; GIANOUTSOS, C; ELISAF, M. S et al.Diabetes & metabolism. 2000, Vol 26, Num 5, pp 403-405, issn 1262-3636Article
Acid-base abnormalities in a patient with hepatic cirrhosisMILIONIS, H. J; ELISAF, M. S.Nephrology, dialysis, transplantation (Print). 1999, Vol 14, Num 6, pp 1599-1601, issn 0931-0509Article
Psoriasiform lesions as paraneoplastic manifestation in Hodgkin's diseaseMILIONIS, H. J; ELISAF, M. S.Annals of oncology. 1998, Vol 9, Num 4, pp 449-452, issn 0923-7534Article
Mechanisms of hypophosphataemia in alcoholic patientsELISAF, M. S; SIAMOPOULOS, K. C.International journal of clinical practice (Esher). 1997, Vol 51, Num 8, pp 501-503, issn 1368-5031Article
Hyperkalaemia in a patient with hepatic cirrhosisMILIONIS, H. J; ELISAF, M. S.Nephrology, dialysis, transplantation (Print). 1999, Vol 14, Num 10, pp 2505-2506, issn 0931-0509Conference Paper
Chronic hyponatremia due to reset osmostat in a patient with colon cancerELISAF, M. S; KONSTANTINIDES, A; SIAMOPOULOS, K. C et al.American journal of nephrology. 1996, Vol 16, Num 4, pp 349-351, issn 0250-8095Article
Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucoseKOSTAPANOS, M. S; MILIONIS, H. J; AGOURIDIS, A.-D et al.International journal of clinical practice (Esher). 2009, Vol 63, Num 9, pp 1308-1313, issn 1368-5031, 6 p.Article
Lipoprotein (a) concentrations in patients with various dyslipidaemiasELISAF, M. S; BAIRAKTARI, E. T; TZALLAS, C. S et al.Annals of medicine (Helsinki). 1997, Vol 29, Num 4, pp 305-309, issn 0785-3890Article
Are the Pleiotropic Effects of Telmisartan Clinically Relevant?RIZOS, C. V; ELISAF, M. S; LIBEROPOULOS, E. N et al.Current pharmaceutical design (Print). 2009, Vol 15, Num 24, pp 2815-2832, issn 1381-6128, 18 p.Article
Association of serum uric acid with cardiovascular disease in rheumatoid arthritisPANOULAS, V. F; MILIONIS, H. J; DOUGLAS, K. M. J et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 9, pp 1466-1470, issn 1462-0324, 5 p.Article
Lipoprotein (a) and acute-phase response in patients with vestibular neuronitisMILIONIS, H. J; MITTARI, V; EXARCHAKOS, G et al.European journal of clinical investigation. 2003, Vol 33, Num 12, pp 1045-1050, issn 0014-2972, 6 p.Article
Acid-base and electrolyte abnormalities in patients with acute leukemiaMILIONIS, H. J; BOURANTAS, C. L; SIAMOPOULOS, K. C et al.American journal of hematology. 1999, Vol 62, Num 4, pp 201-207, issn 0361-8609Article
Effects of conventional vs. low-molecular-weight heparin on lipid profile in hemodialysis patientsELISAF, M. S; GERMANOS, N. P; BAIRAKTARI, H. T et al.American journal of nephrology. 1997, Vol 17, Num 2, pp 153-157, issn 0250-8095Article
Acid-base and electrolyte disturbances in patients with diabetic ketoacidosisELISAF, M. S; TSATSOULIS, A. A; KATOPODIS, K. P et al.Diabetes research and clinical practice. 1996, Vol 34, Num 1, pp 23-27, issn 0168-8227Article
Anticoagulant drugs: what is new?KEI, A; FLORENTIN, M; ELISAF, M. S et al.International angiology. 2011, Vol 30, Num 4, pp 299-320, issn 0392-9590, 22 p.Article
Efficacy of combination of atorvastatin and micronised fenofibrate in the treatment of severe mixed hyperlipidemiaKIORTSIS, D. N; MILLIONIS, H; BAIRAKTARI, E et al.European journal of clinical pharmacology. 2000, Vol 56, Num 9-10, pp 631-635, issn 0031-6970Article
Statin therapy after first stroke reduces 10-year stroke recurrence and improves survivalMILIONIS, H. J; GIANNOPOULOS, S; KOSMIDOU, M et al.Neurology. 2009, Vol 72, Num 21, pp 1816-1822, issn 0028-3878, 7 p.Article
Statin-associated adverse effects beyond muscle and liver toxicityKIORTSIS, D. N; FILIPPATOS, T. D; MIKHAILIDIS, D. P et al.Atherosclerosis. 2007, Vol 195, Num 1, pp 7-16, issn 0021-9150, 10 p.Article
Pathogenesis, detection and treatment of Achilles tendon xanthomasTSOULI, S. G; KIORTSIS, D. N; ARGYROPOULOU, M. I et al.European journal of clinical investigation. 2005, Vol 35, Num 4, pp 236-244, issn 0014-2972, 9 p.Article
Pinpoint skin lesions in a familial hypercholesterolaemia homozygoteMILIONIS, H. J; MILTIADOUS, G. A; CARIOLOU, M et al.Acta paediatrica (Oslo). 2003, Vol 92, Num 9, pp 1109-1110, issn 0803-5253, 2 p.Article
The effect of atorvastatin on serum lipids, lipoprotein(a) and plasma fibrinogen levels in primary dyslipidaemia: A pilot study involving serial samplingGOUDEVENOS, J. A; BAIRAKTARI, E. Th; CHATZIDIMOU, K. G et al.Current medical research and opinion. 2001, Vol 16, Num 4, pp 269-275, issn 0300-7995Article
Lipid abnormalities in chronic uremic patients : response to treatment with gemribrozilELISAF, M. S; DARDAMANIS, M. A; PAPAGALANIS, N. D et al.Scandinavian journal of urology and nephrology. 1993, Vol 27, Num 1, pp 101-108, issn 0036-5599Article
Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitusMILIONIS, H. J; LIBEROPOULOS, E. N; ELISAF, M. S et al.Diabetes & metabolism. 2001, Vol 27, Num 2, pp 160-163, issn 1262-3636Article